Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 174976)

Published in Antimicrob Agents Chemother on October 01, 1987

Authors

S Kit1, M Sheppard, H Ichimura, S Nusinoff-Lehrman, M N Ellis, J A Fyfe, H Otsuka

Author Affiliations

1: Division of Biochemical Virology, Baylor College of Medicine, Houston, Texas 77030.

Articles citing this

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother (2010) 1.73

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol (1997) 1.44

A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A (1994) 1.26

Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother (1992) 1.23

The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol (2010) 1.12

Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2000) 1.09

Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J Virol (2001) 1.09

Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J Virol (1993) 1.05

Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob Agents Chemother (1999) 0.94

Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother (2003) 0.93

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol (2010) 0.88

Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine. Antimicrob Agents Chemother (2001) 0.81

In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. J Virol (2011) 0.80

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

New M13 vectors for cloning. Methods Enzymol (1983) 90.74

Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J (1982) 38.14

The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00

Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol (1966) 14.57

Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1981) 10.04

The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res (1980) 9.96

MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY. Virology (1964) 6.69

Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem (1978) 5.43

rII cistrons of bacteriophage T4. DNA sequence around the intercistronic divide and positions of genetic landmarks. J Mol Biol (1981) 4.76

The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg (Lond) (1978) 4.07

Acquisition of thymidine kinase activity by herpes simplex-infected mouse fibroblast cells. Biochem Biophys Res Commun (1963) 3.62

Homology between human bladder carcinoma oncogene product and mitochondrial ATP-synthase. Nature (1983) 3.34

Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A (1980) 3.32

Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse. EMBO J (1985) 3.25

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28

Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science (1979) 2.23

Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences. Mol Cell Biol (1985) 2.13

Chemical carcinogens as frameshift mutagens: Salmonella DNA sequence sensitive to mutagenesis by polycyclic carcinogens. Proc Natl Acad Sci U S A (1974) 2.12

Molecular basis of a mutational hot spot in the lysozyme gene of bacteriophage T4. Nature (1972) 2.08

Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol (1980) 2.01

Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol (1984) 1.96

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother (1980) 1.96

The nucleotide sequence of the chicken thymidine kinase gene and the relationship of its predicted polypeptide to that of the vaccinia virus thymidine kinase. Nucleic Acids Res (1984) 1.96

Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother (1982) 1.80

Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine. Mol Pharmacol (1983) 1.75

Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. J Virol (1981) 1.74

Nucleotide sequence of the herpes simplex virus type 2 thymidine kinase gene. J Virol (1983) 1.70

Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J Gen Virol (1986) 1.69

Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene. Biochim Biophys Acta (1983) 1.63

Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Mol Pharmacol (1982) 1.55

Herpes simplex virus DNA isolation from infected cells with a novel procedure. Virology (1979) 1.44

Identification of an Epstein-Barr virus-coded thymidine kinase. EMBO J (1986) 1.31

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother (1987) 1.24

Structure and expression of the Chinese hamster thymidine kinase gene. Mol Cell Biol (1986) 1.24

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J Infect Dis (1983) 1.23

Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. J Gen Virol (1983) 1.22

Fowlpox virus thymidine kinase: nucleotide sequence and relationships to other thymidine kinases. Virology (1987) 1.21

Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother (1985) 1.17

Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses. J Clin Microbiol (1983) 1.15

Virus resistance in clinical practice. J Antimicrob Chemother (1983) 1.13

Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol (1986) 1.09

Thymidine kinase. Microbiol Sci (1985) 1.00

A frameshift at a mutational hotspot in the polyoma virus early region generates two new proteins that define T-antigen functional domains. Cell (1986) 0.99

Non-structural protein 1 of parvoviruses: homology to purine nucleotide using proteins and early proteins of papovaviruses. Nucleic Acids Res (1986) 0.98

Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1985) 0.96

Nucleotide sequence of the marmoset herpesvirus thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide. Virology (1984) 0.96

Thymidine kinase (TK) induction after infection of TK-deficient rabbit cell mutants with bovine herpesvirus type 1 (BHV-1): isolation of TK- BHV-1 mutants. Virology (1983) 0.89

Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids. Proc Natl Acad Sci U S A (1977) 0.88

Sequential genital infections by herpes simplex viruses types 1 and 2: restriction nuclease analyses of viruses from recurrent infections. Sex Transm Dis (1984) 0.86

Analysis of the role of the cysteine 171 residue in the activity of herpes simplex virus type 1 thymidine kinase by oligonucleotide-directed mutagenesis. J Gen Virol (1987) 0.80

Cloning of the marmoset herpesvirus thymidine kinase gene and analyses of the boundaries of the coding region. Virology (1981) 0.79

Articles by these authors

(truncated to the top 100)

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A (1977) 11.20

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48

Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc Natl Acad Sci U S A (1990) 6.85

Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem (1978) 5.43

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J Virol (1979) 4.53

Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother (1978) 3.97

Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J Gen Microbiol (1980) 3.37

Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science (1987) 2.51

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet (1999) 2.48

Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal Biochem (1989) 2.41

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 2.38

The instability of mucoid Pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J Gen Microbiol (1979) 2.31

Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine. Nature (1986) 2.30

Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology (1980) 2.18

Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol (1984) 2.15

Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina. J Gen Microbiol (1981) 2.04

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.02

Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J Virol (1992) 2.02

Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem Pharmacol (1981) 1.92

Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun (1998) 1.85

A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab (2010) 1.84

The physiological properties of ascorbic acid: An effect upon the weights of guinea-pigs. Biochem J (1938) 1.79

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A (1986) 1.78

Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine. Mol Pharmacol (1983) 1.75

Sources of selection bias in evaluating social programs: an interpretation of conventional measures and evidence on the effectiveness of matching as a program evaluation method. Proc Natl Acad Sci U S A (1996) 1.74

Rapid alveolar liquid removal by a novel convective mechanism. Am J Physiol Lung Cell Mol Physiol (2001) 1.73

A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res (1983) 1.69

A promoter associated with the neisserial repeat can be used to transcribe the uvrB gene from Neisseria gonorrhoeae. J Bacteriol (1995) 1.68

Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins. Antimicrob Agents Chemother (1981) 1.66

Revised guidelines for control of MRSA in hospitals: finding the most useful point. J Hosp Infect (1999) 1.64

Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene. Biochim Biophys Acta (1983) 1.63

Arterial tonometry for noninvasive, continuous blood pressure monitoring during anesthesia. Anesthesiology (1991) 1.58

Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Mol Pharmacol (1982) 1.55

In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol (1999) 1.52

Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA (1988) 1.51

Control of MRSA. J Hosp Infect (2000) 1.42

An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types. Cancer (1992) 1.42

Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet (1993) 1.42

Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U). Antimicrob Agents Chemother (1987) 1.41

Arrest of 3T3 cells in G1 phase in suspension culture. J Cell Physiol (1975) 1.37

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol (1993) 1.35

A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. Proc Natl Acad Sci U S A (1989) 1.34

Cytoplasmic 5'-nucleotidase catalyzes acyclovir phosphorylation. J Biol Chem (1985) 1.33

NIH Conference. Herpes simplex virus infection: biology, treatment, and prevention. Ann Intern Med (1985) 1.33

Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab (2014) 1.29

Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab (1979) 1.26

Pleuropulmonary blastoma: is prophylactic resection of congenital lung cysts effective? Ann Thorac Surg (2001) 1.26

Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer (1990) 1.25

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother (1987) 1.24

Vitamin B 12 biosynthesis. Enzyme studies on the formation of the alpha-glycosidic nucleotide precursor. J Biol Chem (1969) 1.22

Increase of thymidine, thymidylate and deoxycytidine kinase activites during germination of bacterial spores. Biochim Biophys Acta (1971) 1.21

Q fever pneumonia in children in Japan. J Clin Microbiol (1996) 1.20

Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol (2000) 1.20

Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. Aliment Pharmacol Ther (2002) 1.18

Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother (1985) 1.17

On the formation of 2-keto-3-deoxy-D-glucose. Biochim Biophys Acta (1968) 1.16

Radioiodine for hyperthyroidism. BMJ (1992) 1.16

Mapping and characterization of two mutations to antibiotic supersusceptibility in Pseudomonas aeruginosa. J Gen Microbiol (1987) 1.16

Antitumor activity of shikonin and its derivatives. Chem Pharm Bull (Tokyo) (1977) 1.13

Virus resistance in clinical practice. J Antimicrob Chemother (1983) 1.13

Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine (2001) 1.12

Characterization of canine herpesvirus glycoprotein C expressed by a recombinant baculovirus in insect cells. Virus Res (1996) 1.11

Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus. AIDS Res Hum Retroviruses (2001) 1.10

Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J Interferon Cytokine Res (1999) 1.10

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1991) 1.10

Techniques for reducing anterior knee symptoms after anterior cruciate ligament reconstruction using a bone-patellar tendon-bone autograft. Am J Sports Med (2001) 1.10

6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. Antimicrob Agents Chemother (1991) 1.09

Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations. EMBO J (1998) 1.08

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08

Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Arch Intern Med (1988) 1.08

Mammary fibroadenoma in a young Holstein cow. J Vet Med Sci (1994) 1.08

In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin Diagn Lab Immunol (2001) 1.07

Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J Infect Dis (1990) 1.07

Brain metastases in musculoskeletal sarcomas. Jpn J Clin Oncol (1999) 1.06

Environmental hazards from a hospital incinerator. J Hosp Infect (1989) 1.06

Absence of an SOS-like system in Neisseria gonorrhoeae. Gene (1998) 1.05

The pathogenic neisseriae contain an inactive rpoN gene and do not utilize the pilE sigma54 promoter. Gene (1998) 1.05

Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br (1998) 1.05

Kinetic properties and inhibition of orotidine 5'-phosphate decarboxylase. Effects of some allopurinol metabolites on the enzyme. J Biol Chem (1973) 1.05

Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer (1988) 1.04

Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa. Rev Infect Dis (1984) 1.04

The DUTT1 gene, a novel NCAM family member is expressed in developing murine neural tissues and has an unusually broad pattern of expression. Mol Cell Neurosci (1998) 1.03

Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett (1996) 1.03

Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J Infect Dis (1990) 1.02

Revision total hip arthroplasty using a Kerboull-type acetabular reinforcement device with bone allograft: minimum 4.5-year follow-up results and mechanical analysis. J Bone Joint Surg Br (2011) 1.01

Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses. Antimicrob Agents Chemother (1995) 1.00

Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa. J Gen Microbiol (1984) 1.00

Biochemical transformation of thymidine kinase (TK)-deficient mouse cells by herpes simplex virus type 1 DNA fragments purified from hybrid plasmids. Nucleic Acids Res (1980) 1.00

Thymidine kinase. Microbiol Sci (1985) 1.00

Differences in the rates of protein degradation in untrasformed and transformed cell lines. Exp Cell Res (1978) 0.99

Neisseria gonorrhoeae contains multiple copies of a gene that may encode a site-specific recombinase and is associated with DNA rearrangements. Gene (1998) 0.99

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism (1996) 0.99

Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med (2007) 0.99

Ribonuclease from Streptomyces erythreus. Purification and properties. Biochim Biophys Acta (1971) 0.98

3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus. J Virol (1987) 0.98

A ceramic prosthesis for the treatment of tumours of the distal radius. J Bone Joint Surg Br (2006) 0.98

A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan. Asia Oceania J Obstet Gynaecol (1992) 0.97

Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer (1990) 0.97

Nucleotide sequence of the marmoset herpesvirus thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide. Virology (1984) 0.96

The physiological properties of ascorbic acid: The increase in metabolism of guinea-pigs on a diet deficient in ascorbic acid. Biochem J (1939) 0.96